Drug firm Divi's Laboratories Tuesday said income tax department has conducted raids at its premises, including its head office and manufacturing sites, between February 14-18.
The company said the raids were conducted by the officials of Income-Tax Department under Section 132 of the Income-Tax Act.
"The company has extended full cooperation to the officials during the search and provided all the information sought. The search operation concluded on February 18, 2019 and no irregularities have been found," Divi's Laboratories said in a regulatory filing.
Established in 1990, Divi's is a leading manufacturer of active pharmaceutical ingredients offering products in over 95 countries.
The company's shares were trading 0.66 per cent up at Rs 1,585 on the BSE.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)